|
Stage |
T |
N |
M |
|
|
Latent |
x |
0 |
0 |
|
|
Stage 0 |
is |
0 |
0 |
|
|
Stage IA1 |
1(mi) |
0 |
0 |
Surgery with or without adjuvant therapy, radiation therapy |
|
1a |
0 |
0 |
||
|
Stage IA2 |
1b |
0 |
0 |
|
|
Stage IA3 |
1c |
0 |
0 |
|
|
Stage IB |
2a |
0 |
0 |
|
|
Stage IIA |
2b |
0 |
0 |
Surgery with or without adjuvant and/or neoadjuvant therapy, radiation therapy |
|
Stage IIB |
1a, 1b, 1c |
1 |
0 |
|
|
2a |
1 |
0 |
||
|
2b |
1 |
0 |
||
|
3 |
0 |
0 |
||
|
Stage IIIA |
1a, 1b, 1c |
2 |
0 |
Resected or resectable disease: Surgery with or without adjuvant and/or neoadjuvant therapy, immunotherapy, chemoradiation Unresectable disease: Chemoradiation, radiation therapy, targeted therapy, immunotherapy Superior sulcus tumors: Surgery, chemoradiation followed by surgery, radiation therapy alone Tumors that invade the chest wall: Surgery, surgery and radiation therapy, radiation therapy alone, chemotherapy combined with radiation therapy and/or surgery
|
|
2a, 2b |
2 |
0 |
||
|
3 |
1 |
0 |
||
|
4 |
0, 1 |
0 |
||
|
Stage IIIB |
1a, 1b, 1c |
3 |
0 |
Sequential or concurrent chemotherapy and radiation therapy, radiation therapy alone, targeted therapy, immunotherapy |
|
2a, 2b |
3 |
0 |
||
|
3 |
2 |
0 |
||
|
4 |
2 |
0 |
||
|
Stage IIIC |
3 |
3 |
0 |
Sequential or concurrent chemotherapy and radiation therapy, radiation therapy alone, targeted therapy, immunotherapy |
|
4 |
3 |
0 |
||
|
Stage IVA |
Any |
Any |
1a, 1b |
Chemotherapy, targeted therapy, immunotherapy, radiation therapy (for palliation) or symptomatic treatment |
|
Stage IVB |
Any |
Any |
1c |
|
|
Based on Amin MB, Edge S, Greene F, et al, eds. AJCC Cancer Staging Manual (8th edition). Springer International Publishing: American Joint Commission on Cancer; 2017. Updated from the National Cancer Institute. Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version. Updated August 30, 2024. |
||||
|
TNM, tumor, node, metastasis. |
||||